Shionogi Inc Drug Patent Portfolio

Shionogi Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Shionogi Inc News

The post-antibiotic age has arrived, and low- and middle-income countries must not be overlooked.

26 May, 2025

Goodwin Advises Apnimed on Securing Worldwide Patent Rights for Sulthiame, a ...

01 May, 2025

See More